ASTORA Women's Health

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, ASTORA Women's Health sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 4 completed later-stage tilt upper quartile by trial count

ASTORA Women's Health: 7 sponsored US clinical trials, none currently recruiting.

ASTORA Women's Health sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Fecal Incontinence, with 1 trials.

Upper-quartile sponsor footprint

ASTORA Women's Health sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

TERMINATED Phase 4

Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse

NCT02123992
TERMINATED Phase 4

Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse

NCT02121977
TERMINATED

Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices

NCT01673360
COMPLETED NA

Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence

NCT01090739
COMPLETED Phase 1

Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms

NCT00565136
COMPLETED

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

NCT00388947
COMPLETED

Pelvic Floor Repair Systems for Prolapse Repair

NCT00638235

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 2

Therapeutic Areas

Fecal Incontinence 1

How the ASTORA Women's Health archive is shaped

7 indexed studies, none listed as recruiting (0% open); 4 completed (57%).

Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Fecal Incontinence (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

ASTORA Women's Health: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

ASTORA Women's Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share ASTORA Women's Health3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
ASTORA Women's Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

ASTORA Women's Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this ASTORA Women's Health page

7 registered trials is a research-attention snapshot, not an endorsement of ASTORA Women's Health or any single study.

  • None of ASTORA Women's Health's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Fecal Incontinence is the condition ASTORA Women's Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fecal Incontinence trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

ASTORA Women's Health pipeline card: 7 registered trials from official public datasets.Report a data error.